Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Transcatheter-Arterial embolization (TAE) is an established regional, palliative treatment option for liver metastases in patients (pts) with neuroendocrine neoplasms (NENs).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Rowland S, Armeni E, Sullivan L, Aristidou I, Gopaul A,
Keywords: NEN, TAE, metastatic liver burden,
Introduction: Gastrointestinal neuroendocrine neoplasms (GI-NENs) is a highly heterogeneous tumor. The accuracy of pathological diagnosis on the biopsy is crucial for GI-NENs but rarely investigated
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Sun L
Authors: Sun L, Li S, Li J, Lu M, Luo J,
Keywords: Gastrointestinal neuroendocrine neoplasm, morphology, Immunohistochemistry,
Introduction: Urinary 5-hydroxyindoleacetic acid (U-5HIAA) is a useful marker for serotonin-producing neuroendocrine tumors (NETs). Its prognostic role, however, is yet to be fully elucidated.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Bartholomew T, Garcia-Hernandez J, Rossi R, Braude D, Mullan M,
Introduction: GEP-NETs are rare, heterogeneous neoplasms with a distinct biological and clinical behavior. Both IGF-system and Ki-67 indices have been reported as important stimulating factors in carcinogenesis and/or tumor progression. The tumor marker CgA is an independent predictor for survival as well. Currently no data are available about a possible interaction between IGF-system (IGF(-R)s, IRs, BPs) and Ki-67 protein in GEP-NET patients with normal and elevated serum CgA.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: van Adrichem R
Authors: Van Adrichem R, De Herder W, Feelders R, De Martino C, De Krijger R,
Keywords: GEP-NET,
#498 Limitations of Chromogranin A in Clinical Practice
Introduction: Chromogranin-A (CgA) is the most accurate marker for the histological diagnosis of neuroendocrine tumors (NETs). However diagnostic usefulness of circulating CgA is controversial as several conditions, both neoplastic and non-neoplastic, may induce false positive increases of this marker.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Marotta V, Nuzzo V, Ferrara T, Zuccoli A, Del Prete M,
Keywords: Chromogranin A, neuroendocrine tumor, false positive marker,